ENBIO (352940) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ENBIO (352940) reported revenue of 34.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202534.0 billion KRW917 million KRW1.0 billion KRW[source]
202435.7 billion KRW1.4 billion KRW646 million KRW[source]
202334.0 billion KRW-3.4 billion KRW-6.3 billion KRW[source]
202234.2 billion KRW-4.8 billion KRW-3.4 billion KRW[source]
202133.5 billion KRW1.1 billion KRW5.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202569.1 billion KRW26.8 billion KRW42.4 billion KRW[source]
202467.8 billion KRW26.4 billion KRW41.4 billion KRW[source]
202366.3 billion KRW25.6 billion KRW40.7 billion KRW[source]
202287.4 billion KRW40.9 billion KRW46.5 billion KRW[source]
202190.6 billion KRW40.7 billion KRW49.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice